GENERAL, O. Reg. 256/24
Schedule 1
Cite as GENERAL, O. Reg. 256/24, Schedule 1 · current to November 11, 2026 · consolidated from September 30, 2026 · read from e-Laws on November 16, 2026
The text
Schedule 1 Injected Substances
Analgesics and Antipyretics
Codeine — For patient education and demonstration only
Hydromorphone — For patient education and demonstration only
Morphine — For patient education and demonstration only
Nalbuphine — For patient education and demonstration only
Antibacterials
Amikacin
Ampicillin
Cefazolin
Cefepime
Cefotaxime
Cefoxitin
Ceftazidime
Ceftriaxone
Clindamycin
Cloxacillin
Ertapenem
Gentamicin
Penicillin G
Anticholinergic Agents
Glycopyrrolate — Must not be administered intravenously
Hyoscine — Must not be administered intravenously
Scopolamine — Must not be administered intravenously
Anticoagulants
Dalteparin — Must not be administered intravenously
Danaparoid — Must not be administered intravenously
Enoxaparin — Must not be administered intravenously
Fondaparinux — Must not be administered intravenously
Heparin — For patient education and demonstration only
Nadroparin — Must not be administered intravenously
Tinazaparin
Antidiabetic Agents
Dulaglutide
Exenatide
Insulins
Liraglutide
Lixisenatide
Semaglutide
Tirzepatide
Antihemorrhagic Agents
Emicizumab
Antihistamines
Dimenhydrinate — Must not be administered intravenously
Diphenhydramine — Only for monitoring and management of allergic reactions
Antimigraine Agents
Erenumab
Sumatriptan
Antiparkinsonian Agents
Apomorphine
Benztropine
Antivirals
Enfuvirtide
Interferons
Peginterferon alfa-2a
Central Nervous System Agents, Miscellaneous
Inotersen
Complement Inhibitors
Icatibant
Lanadelumab
Disease-modifying Antirheumatic Drugs
Abatacept
Adalimumab
Anakinra
Etanercept
Golimumab — Must not be administered intravenously
Methotrexate — Must not be administered intravenously
Sarilumab
Tocilizumab — Must not be administered intravenously
Ustekinumab — Must not be administered intravenously
Enzymes
Asfotase Alfa
GI Drugs, Miscellaneous
Certolizumab Pegol
Methylnaltrexone
Gonadotropins and Antigonadotropins
Follitropin-alpha
Follitropin-beta
Follitropin-delta
Gonadotropin-chorionic
Gonadotropin-chorionic-alfa
Goserelin — For patient education and demonstration only
Leuprolide — For patient education and demonstration only
Lutropin-alfa
Menotropins
Triptorelin acetate
Gonadotropin-releasing Hormone Antagonists
Cetrorelix
Ganirelix
Heavy Metal Antagonists
Deferoxamine — For patient education and demonstration only
Hematopoietic Agents
Darbepoetin alfa — Must not be administered intravenously
Epoetin alfa — Must not be administered intravenously
Filgrastim — Must not be administered intravenously
Pegfilgrastim
Romiplostim — For patient education and demonstration only
Immunomodulatory Agents
Denosumab
Glatiramer
Interferon-Beta-1A
Interferon-Beta-1B
Natalizumab
Immunosuppressive Agents
Belimumab — Must not be administered intravenously
Mepolizumab
Miscellaneous Agents
Sodium Chloride
Sterile Water for Injection (Diluent)
Parathyroid
Calcitonin Salmon — For patient education and demonstration only
Teriparatide
Pituitary
Desmopressin — For patient education and demonstration only
Vasopressin — For patient education and demonstration only
Progestins
Medroxyprogesterone
Progesterone
Prokinetic Agents
Metoclopramide
Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9) Inhibitors
Alirocumab
Evolocuma
Psychotherapeutic Agents
Haloperidol — For patient education and demonstration only
Methotrimeprazine — For patient education and demonstration only
Respiratory Tract Agents
Omalizumab
Skin And Mucous Membrane Agents
Brodalumab
Dupilumab
Guselkumab
Ixekizumab
Risankizumab — Must not be administered intravenously
Secukinumab
Somatostatin Agonists and Antagonists
Lanreotide
Octreotide — Must not be administered intravenously
Pasireotide
Somatotropin Agonists and Antagonists
Pegvisomant
Somatropin
Tesamorelin
Sympatholytic (Adrenergic Blocking) Agents
Dihydroergotamine — Must not be administered intravenously
Vitamins
Ascorbic Acid — Must not be administered intravenously
Cyanocobalamin
Folic Acid — Must not be administered intravenously
Pyridoxine — Must not be administered intravenously
Thiamine — Must not be administered intravenously
Vitamin K
Read the GENERAL on e-Laws ↗
Made under Pharmacy Act, 1991, S.O. 1991, c. 36.